Albemarle Corporation
ALB Basic Materials Chemicals - Specialty NYSE
$162.29
$-1.64 (-1.00%)
Open: $158.62 | High: $165.05 | Low: $158.00 | Prev Close: $163.93
Market Cap: $19.13B
Volume: 2.2M | Avg: 3.0M
Last updated: March 09, 2026 at 02:00 AMInvestment Rating
Strong Sell
Overall Score: 20/100
Rating Breakdown:
Stock Score Analysis
Stock Score: 465
Comprehensive Quality Assessment
Component Breakdown:
Valuation Metrics
| P/E Ratio | -28.47 |
| P/B Ratio | 2.00 |
| P/S Ratio | 3.72 |
| EPS | $-5.70 |
| Beta | 1.48 |
| Shares Outstanding | 117.85M |
| 52-Week High | $206.00 |
| 52-Week Low | $49.43 |
| SMA 50 | $168.21 |
| SMA 200 | $107.06 |
| Dividend Yield | 1.00% |
| Annual Dividend | $1.62 |
| Next Earnings | April 29, 2026 09:00 PM ET |
Financial Ratios
| Gross Margin | 13.1% |
| Operating Margin | 1.7% |
| Net Margin | -9.9% |
| ROE | -5.1% |
| ROA | -3.1% |
| Debt/Equity | 0.35 |
| Current Ratio | 2.23 |
| Quick Ratio | 1.57 |
Balance Sheet
| Total Assets | $16.37B |
| Total Liabilities | $6.59B |
| Total Equity | $9.53B |
|
|
|
| Cash | $1.62B |
| Total Debt | $3.30B |
| Net Debt | $1.68B |
Income Statement
| Revenue | $5.14B |
| Gross Profit | $671.62M |
| Operating Income | $93.79M |
| Net Income | $-510,628,000 |
|
|
|
| EBITDA | $754.37M |
| Revenue/Share | $43.69 |
Cash Flow
| Operating CF | $1.28B |
| CapEx | $589.80M |
| Free Cash Flow | $692.47M |
|
|
|
| Book Value/Share | $83.10 |
| Tangible Book/Share | $68.54 |
| Equity/Share | $81.00 |
Technical Indicators
| RSI (14) | 48.89 Neutral |
| MACD |
0.54
Signal: 2.75
|
| Volatility | 62.36% |
| Trading Signal | Bearish |
Performance & Returns
| 1 Year | +173.95% |
| Sharpe Ratio | 2.33 Excellent |
| Volatility (Ann.) | 61.17% High Risk |
| ALB (1Y) | +173.95% |
| S&P 500 (1Y) | +13.03% |
| Alpha (Excess Return) | +160.92% |
Sector Comparison (Basic Materials)
| Metric | ALB | Sector Avg | Percentile |
|---|---|---|---|
| P/E Ratio | -28.47 | 17.33 | 10% |
| P/B Ratio | 2.0 | 3.52 | 30% |
| ROE (%) | -5.13% | 13.13% | 10% |
| Net Margin (%) | -9.93% | 8.54% | 0% |
| Stock Score | 465 | 502.0 | 30% |
| 1Y Return (%) | +173.95 % | +20.01 % | 95% |
📊 Historical Price Analysis (Last 200 Days)
Loading chart...
Technical Analysis
| Ticker | Close | SMA 5 | SMA 8 | SMA 13 | SMA 50 | SMA 200 | RSI (14) | MACD | Volatility (%) | Volume | Signal | SMA Decision |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALB | $162.29 | $167.38 | $175.44 | $175.34 | $168.20 | $107.05 | 48.89 | 0.54 | 62.36% | 1403198 | Weak Short | Price Below SMAs |
Candlestick Patterns
There wasn't any recognizable pattern for the ALB stock
News Sentiment
| 📊 Ticker | 📰 Headline | 💭 Sentiment | 📡 Source | 🔗 URL |
|---|---|---|---|---|
| ALB | Albemarle (ALB) Sees a More Significant Dip Than Broader Market: Some Facts to Know | Neutral | zacks.com | Read More |
| ALB | Why Is Albemarle (ALB) Up 3.1% Since Last Earnings Report? | Neutral | zacks.com | Read More |
| ALB | Wall Street Bulls Look Optimistic About Albemarle (ALB): Should You Buy? | Neutral | zacks.com | Read More |
| ALB | Albemarle (ALB) Declines More Than Market: Some Information for Investors | Negative | zacks.com | Read More |
| ALB | Dimensional Fund Advisors LP Has $119.71 Million Position in Albemarle Corporation $ALB | Neutral | defenseworld.net | Read More |
Recent Insider Trading
| Date | Insider | Position | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-12 | Masters J Kent | director, officer: Chairman & CEO | SELL | 30716 | $162.79 | $5000258 |
| 2026-03-10 | Masters J Kent | director, officer: Chairman & CEO | SELL | 5395 | $170.26 | $918553 |
| 2026-03-10 | Masters J Kent | director, officer: Chairman & CEO | SELL | 5392 | $171.18 | $923003 |
| 2026-03-10 | Masters J Kent | director, officer: Chairman & CEO | SELL | 996 | $171.82 | $171133 |
| 2026-02-27 | LaBauve Donald J. Jr. | officer: VP, Corporate Controller & CAO | BUY | 1266 | $178.67 | $226196 |
| 2026-02-27 | LaBauve Donald J. Jr. | officer: VP, Corporate Controller & CAO | SELL | 361 | $178.67 | $64500 |
| 2026-02-26 | Norris Eric | officer: Chief Commercial Officer | BUY | 1806 | $184.93 | $333984 |
| 2026-02-26 | Norris Eric | officer: Chief Commercial Officer | SELL | 785 | $184.93 | $145170 |
| 2026-02-26 | Mummert Mark Richard | officer: Chief Supply Chain Officer | BUY | 366 | $184.93 | $67684 |
| 2026-02-26 | Mummert Mark Richard | officer: Chief Supply Chain Officer | SELL | 159 | $184.93 | $29404 |
Company Information
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
| CEO | Jerry Kent Jr. |
| Employees | 8300 |
| Country | US |
| IPO Date | 1994-02-22 |
| Exchange | NYSE |
| Website | https://www.albemarle.com |
| Sector | Basic Materials |
| Industry | Chemicals - Specialty |
Similar Stocks (Basic Materials - Chemicals - Specialty)
Rating Metrics Explained
DCF Score (Discounted Cash Flow)
Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.
ROE Score (Return on Equity)
Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.
ROA Score (Return on Assets)
Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.
D/E Score (Debt-to-Equity)
Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.
P/E Score (Price-to-Earnings)
Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.
P/B Score (Price-to-Book)
Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.
Rating Recommendations:
Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:
-
Strong Buy (5/5): Excellent score - strong positive indicator
- The metric significantly outperforms industry averages (top 20% of companies)
- Indicates exceptional financial health or attractive valuation in that category
-
Buy (4/5): Good score - positive indicator
- Above-average performance (top 40% of companies)
- Shows strong fundamentals with room for improvement
-
Neutral (3/5): Average score - neutral indicator
- Performance in line with industry median (middle 20%)
- Neither significantly positive nor negative signal
-
Sell (2/5): Below average - negative indicator
- Below-average performance (bottom 40% of companies)
- Suggests weakness in this particular metric
-
Strong Sell (1/5): Poor score - strong negative indicator
- Significantly underperforms industry (bottom 20%)
- Indicates potential risk or overvaluation in that category